The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Liu David Y since year 2005.
The trader's CIK number is 1675881.
At the time of this reporting, Liu David Y is the Chief Scientific Officer of Protagonist Therapeutics, Inc .
(stock ticker symbol PTGX).
See this page for all insider trading activities at Protagonist Therapeutics, Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-03-12||PTGX||Protagonist Therapeutics, Inc||Option Ex||3,500||4.21||14,735|
|2018-03-12||PTGX||Protagonist Therapeutics, Inc||Sale||3,500||21.29||74,501|
|2018-03-02||PTGX||Protagonist Therapeutics, Inc||Option Ex||875||1.89||1,653|
|2018-03-02||PTGX||Protagonist Therapeutics, Inc||Sale||875||20.00||17,500|
|2018-01-16||PTGX||Protagonist Therapeutics, Inc||Sale||875||20.00||17,500|
|2018-01-16||PTGX||Protagonist Therapeutics, Inc||Option Ex||875||1.89||1,653|
|2017-12-18||PTGX||Protagonist Therapeutics, Inc||Option Ex||875||1.89||1,653|
|2017-12-18||PTGX||Protagonist Therapeutics, Inc||Sale||875||20.00||17,500|
|2017-11-30||PTGX||Protagonist Therapeutics, Inc||Sale||875||20.00||17,500|
|2017-11-13||PTGX||Protagonist Therapeutics, Inc||Option Ex||7,000||3.05||21,350|
|2017-11-13||PTGX||Protagonist Therapeutics, Inc||Sale||7,000||16.97||118,762|
|2017-08-28||PTGX||Protagonist Therapeutics, Inc||Option Ex||3,500||4.21||14,735|
|2017-08-28||PTGX||Protagonist Therapeutics, Inc||Sale||3,500||15.00||52,500|
|2017-07-10||PTGX||Protagonist Therapeutics, Inc||Option Ex||3,500||1.89||6,615|
|2017-07-10||PTGX||Protagonist Therapeutics, Inc||Sale||3,500||12.68||44,380|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Liu David Y (Chief Scientific Officer of Protagonist Therapeutics, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.